- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare ICICI Prudential MNC Fund vs UTI MNC Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.13 | 2.03 |
NAV | ₹28.12 | ₹390.67 |
Fund Started | 28 May 2019 | 01 Aug 2005 |
Fund Size | ₹1676.89 Cr | ₹2867.46 Cr |
Exit Load | Exit load of 1% if redeemed within 12 months. | Exit load of 1% if redeemed less than 1 year |
Risk
Very High
Very High
Rating
-
-
Min SIP Amount
₹100
₹500
Expense Ratio
2.13
2.03
NAV
₹28.12
₹390.67
Fund Started
28 May 2019
01 Aug 2005
Fund Size
₹1676.89 Cr
₹2867.46 Cr
Exit Load
Exit load of 1% if redeemed within 12 months.
Exit load of 1% if redeemed less than 1 year
Returns
1 Year | -1.19% | -3.79% |
3 Year | 16.76% | 15.12% |
5 Year | 22.89% | 15.32% |
1 Year
-1.19%
-3.79%
3 Year
16.76%
15.12%
5 Year
22.89%
15.32%
Holding Analysis
Equity | 96.54% | 94.95% |
Cash | 3.46% | 4.65% |
Equity
96.54%
94.95%
Cash
3.46%
4.65%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Hindustan Unilever Ltd. | 9.07% |
Maruti Suzuki India Ltd. | 9.02% |
Sun Pharmaceutical Industries Ltd. | 6.56% |
Vedanta Ltd. | 4.01% |
Gland Pharma Ltd. | 3.21% |
United Breweries Ltd. | 3.03% |
Nestle India Ltd. | 2.93% |
Hyundai Motor India Ltd. | 2.78% |
Britannia Industries Ltd. | 2.67% |
CIE Automotive India Ltd. | 2.51% |
Name | Assets |
|---|---|
Maruti Suzuki India Ltd. | 8.97% |
Nestle India Ltd. | 5.52% |
Procter & Gamble Health Ltd. | 4.96% |
United Spirits Ltd. | 4.27% |
Vedanta Ltd. | 4.03% |
Hindustan Unilever Ltd. | 3.68% |
Britannia Industries Ltd. | 3.35% |
3M India Ltd. | 2.93% |
Procter & Gamble Hygiene and Health Care Ltd. | 2.53% |
Gland Pharma Ltd. | 2.42% |
Fund Manager
Name | Roshan Chutkey | Karthikraj Lakshmanan |
Start Date | 23 Nov 2020 | 16 Nov 2022 |
Name
Roshan Chutkey
Karthikraj Lakshmanan
Start Date
23 Nov 2020
16 Nov 2022
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities within MNC space. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of multinational companies. |
Launch Date | 28 May 2019 | 01 Aug 2005 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities within MNC space.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of multinational companies.
Launch Date
28 May 2019
01 Aug 2005